Daily activity audit — steps + cadence from a wearable/phone — Boston.

Boston, MA is home to Harvard Medical School and the Harvard T.H. Chan School of Public Health, where Dr. I-Min Lee -- whose research established the dose-response relationship between daily step count and mortality -- has been a professor since 1993, maintaining a parallel affiliation with Brigham and Women's Hospital. A distinct connection from this library's existing Dallas tile, which is built on that city's own car-dependent incidental-walking deficit rather than the underlying science's academic origin, and a distinct reason from this library's existing Boston tile for `circadian_light_anchoring` (Czeisler's light-entrainment research, not step-count epidemiology).

Where

Home / daily-life step data, Boston, MA · Open the map

Pay

$200 proposed

This packet is not funded yet, so this figure is a proposed price and not money waiting in escrow. If a buyer funds it, approved proof settles that price onchain. If nobody funds it, approved proof earns provable credit toward the work instead of cash — recorded, and readable any time at vealth.net/labor/credit/(your wallet). You see which before you claim, never after.

Proof

7-day average daily steps + peak sustained cadence (steps/min) vs age-appropriate dose-response context, with a coached volume-then-intensity progression

This is exactly what gets it approved. Nothing settles without it.

Level

entry

Open until

2026-12-31

Posted by

0x034F…6c89

The creator wallet. Its signature is what approves proof and settles the wage.

How this work is done

A documented method, so this packet comes out the same whoever does it.

Bring

• a validated step counter (wearable or phone pedometer)
• 7 consecutive days of wear/log
• the device's cadence or steps/min readout (if available)
• a note on mobility aids / gait limitations
• PAR-Q+ or clinician clearance note for new exercisers

Steps

1. 1. Confirm the device is worn consistently for 7 full days (or logged), and note any mobility aid, injury, or gait limitation affecting the step data. Screen new exercisers with PAR-Q+; route symptoms to a clinician before adding intensity.
2. 2. Record average daily steps across the 7 days (drop obvious non-wear days and note them).
3. 3. Record peak sustained cadence (best steps/min over ~30 min) as the intensity marker; >=100 steps/min approximates moderate intensity.
4. 4. Compare average steps to the age-appropriate dose-response context (benefit rising toward ~7,000-8,000/day in older adults, higher in younger) as a trend/goal, not a prescription or diagnosis.
5. 5. Set a conservative coached progression: add ~500-1,000 steps/day increments toward the goal, then build cadence with short brisk intervals once volume is stable; respect joint/cardiac limits.
6. 6. Record the 7-day average, peak cadence, comparison, screen result, and progression plan; sign. Route any red flag to a clinician.

What counts as done

• 7 consecutive days of step data with any non-wear days noted
• Average daily steps + peak sustained cadence (steps/min) recorded
• Comparison to the age-appropriate dose-response context (trend/goal, not a diagnosis)
• Coached progression recorded (add volume first, then build cadence), with any symptom routed to a clinician

Proof is measured against these, not judged by taste.